Therapy News and Research

RSS

Intensive medical therapy may benefit patients with asymptomatic plaque buildup

Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.

15 Dec 2009

OU lab completes studies on new type of training technique

Bemben's lab at the university is currently only one of four labs outside of Japan that has been working with the KAATSU-Master training system, testing the effectiveness of reducing blood flow to exercising muscle.

15 Dec 2009

Scientists identify protein switch that helps prevent liver cancer

A team of scientists from the UC San Diego School of Medicine and Osaka University in Japan have identified a protein switch that helps prevent liver damage, including inflammation, fibrosis and cancer. The findings suggest that a better understanding of how the protein, TAK1, works could lead to new insights into the development of liver disease and cancer.

15 Dec 2009

CureDM receives patent allowance for novel islet neogenesis program

CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.

15 Dec 2009

Update on new clinical developments and other initiatives related to Ceplene

EpiCept Corporation today provided an update on new clinical developments and other initiatives related to Ceplene® (histamine dihydrochloride), the Company’s therapy approved in the European Union for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.

15 Dec 2009

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Geron Corporation today announced that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has granted Geron’s request to declare an interference between a patent application owned by Geron and U.S. Patent No. 7,510,876 (the ‘876 patent) owned by Novocell, Inc.

15 Dec 2009

Anthem Blue Cross to receive Tri-County Commercial contract renewal award

Anthem Blue Cross announced today that the California Department of Health Care Services intends to award Anthem the Tri-County Commercial contract renewal to provide Medi-Cal benefits to residents in the Fresno, Kings and Madera Counties.

15 Dec 2009

Nanoparticle could allow diagnosis and treatment in one visit

Researchers at Rice University and Baylor College of Medicine (BCM) have created a single nanoparticle that can be tracked in real time with MRI as it homes in on cancer cells, tags them with a fluorescent dye and kills them with heat.

15 Dec 2009

New program to help maintain bone health in men with prostate cancer on ADT announced

Watson Pharmaceuticals, Inc. today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy (ADT).

15 Dec 2009

Manchester Pharmaceuticals' Chenodal now available for patients suffering from gallstones

Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an important therapy for patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age.

15 Dec 2009

Demystifying Psychiatry: A resource for patients and families

Psychiatric disorders are underdiagnosed, poorly treated and highly stigmatized, according to psychiatrists Charles F. Zorumski, M.D., and Eugene H. Rubin, M.D., Ph.D. So these Washington University physicians have written a book to address those problems.

15 Dec 2009

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Researchers at the Los Angeles Biomedical Research Institute (LA BioMed) expect to receive more than $4.5 million in grants from the American Recovery and Reinvestment Act (Recovery Act.), including nearly $1 million from the highly competitive Challenge Grant program for a study that seeks to reduce the number of children who die from Sudden Infant Death Syndrome, it was announced today.

15 Dec 2009

ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS

The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

15 Dec 2009

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

The University of Michigan Health System has received a $15 million gift from the Ted and Jane Von Voigtlander Foundation, the largest gift ever made to the Health System for women's health. It will support the construction of a new women's hospital.

15 Dec 2009

Amgen receives worldwide rights to Array’s small-molecule glucokinase activator program

Array BioPharma Inc. and Amgen Inc.(NASDAQ: AMGN) today announced that they entered into an agreement granting Amgen exclusive worldwide rights to Array’s small-molecule glucokinase activator program, including ARRY-403, currently being tested in a Phase 1 clinical trial in patients with Type 2 diabetes.

14 Dec 2009

Alcon signs definitive agreement to acquire Optonol

Alcon announced today that it has entered into a definitive agreement to acquire Optonol, Ltd., a medical device company that develops, manufactures and markets novel miniature surgical implants used to lower intraocular pressure (IOP) in patients with glaucoma.

14 Dec 2009

Montreal Heart Institute performs landmark procedure

The electrophysiology team at the Montreal Heart Institute (MHI) recently performed the first implantation of a new type of cardiac pacemaker (Accent RF(TM)) in Canada.

14 Dec 2009

New technological system to help improve availability of anti-malarial drugs in Tanzania

A new solution developed by IBM ( IBM), Novartis and Vodafone with the Roll Back Malaria Partnership, is helping to save lives using everyday technology to improve the availability of anti-malarial drugs in remote areas of Tanzania.

14 Dec 2009

Detroit-area residents plead guilty in connection with health care fraud schemes

Detroit-area residents Baskaran Thangarasan, Sandeep Aggarwal and Wayne Smith pleaded guilty this week for their roles in connection with several Detroit-area health care fraud schemes, Assistant Attorney General Lanny Breuer of the Criminal Division, U.S. Attorney for the Eastern District of Michigan Terrence I. Berg, Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office and Daniel Levinson, Inspector General for the U.S. Department of Health and Human Services (HHS) announced today.

14 Dec 2009

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers.

14 Dec 2009

Therapy News and Research

Intensive medical therapy may benefit patients with asymptomatic plaque buildup

OU lab completes studies on new type of training technique

Scientists identify protein switch that helps prevent liver cancer

CureDM receives patent allowance for novel islet neogenesis program

Update on new clinical developments and other initiatives related to Ceplene

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Anthem Blue Cross to receive Tri-County Commercial contract renewal award

Nanoparticle could allow diagnosis and treatment in one visit

New program to help maintain bone health in men with prostate cancer on ADT announced

Manchester Pharmaceuticals' Chenodal now available for patients suffering from gallstones

Demystifying Psychiatry: A resource for patients and families

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

Amgen receives worldwide rights to Array’s small-molecule glucokinase activator program

Alcon signs definitive agreement to acquire Optonol

Montreal Heart Institute performs landmark procedure

New technological system to help improve availability of anti-malarial drugs in Tanzania

Detroit-area residents plead guilty in connection with health care fraud schemes

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News